IL289869A - Estrogen receptor modulating compounds - Google Patents

Estrogen receptor modulating compounds

Info

Publication number
IL289869A
IL289869A IL289869A IL28986922A IL289869A IL 289869 A IL289869 A IL 289869A IL 289869 A IL289869 A IL 289869A IL 28986922 A IL28986922 A IL 28986922A IL 289869 A IL289869 A IL 289869A
Authority
IL
Israel
Prior art keywords
estrogen receptor
modulating compounds
modulating
compounds
estrogen
Prior art date
Application number
IL289869A
Other languages
English (en)
Hebrew (he)
Original Assignee
Radius Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Radius Pharmaceuticals Inc filed Critical Radius Pharmaceuticals Inc
Publication of IL289869A publication Critical patent/IL289869A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • A61K31/41621,2-Diazoles condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL289869A 2019-07-22 2022-01-16 Estrogen receptor modulating compounds IL289869A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962876963P 2019-07-22 2019-07-22
PCT/US2020/042903 WO2021016254A1 (en) 2019-07-22 2020-07-21 Estrogen receptor-modulating compounds

Publications (1)

Publication Number Publication Date
IL289869A true IL289869A (en) 2022-03-01

Family

ID=71995156

Family Applications (1)

Application Number Title Priority Date Filing Date
IL289869A IL289869A (en) 2019-07-22 2022-01-16 Estrogen receptor modulating compounds

Country Status (10)

Country Link
US (1) US20220281875A1 (zh)
EP (1) EP4003996A1 (zh)
JP (1) JP2022541610A (zh)
KR (1) KR20220035942A (zh)
AU (1) AU2020315812A1 (zh)
BR (1) BR112022000553A2 (zh)
CA (1) CA3146365A1 (zh)
IL (1) IL289869A (zh)
MX (1) MX2022000520A (zh)
WO (1) WO2021016254A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113105329B (zh) * 2021-04-22 2023-10-03 成都道合尔医药技术有限公司 一种(e)-甲酯3-(3,5-二氟-4-甲酰基苯基)丙烯酸的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2300857B (en) * 1995-05-19 1998-07-08 Pharmacia Spa Indazole [3,2-e] -pyrrole and 1,2,3 -benzotriazole [3,2-e] -pyrrole derivatives
CA3089298A1 (en) * 2018-01-22 2019-07-25 Radius Pharmaceuticals, Inc. Estrogen receptor-modulating compounds

Also Published As

Publication number Publication date
WO2021016254A1 (en) 2021-01-28
JP2022541610A (ja) 2022-09-26
KR20220035942A (ko) 2022-03-22
EP4003996A1 (en) 2022-06-01
AU2020315812A1 (en) 2022-03-17
MX2022000520A (es) 2022-02-10
BR112022000553A2 (pt) 2022-05-17
US20220281875A1 (en) 2022-09-08
CA3146365A1 (en) 2021-01-28
CN114174297A (zh) 2022-03-11

Similar Documents

Publication Publication Date Title
IL304460A (en) Estrogen receptor modulating compounds
IL291172A (en) new compounds
GB201905721D0 (en) Compounds
IL286461A (en) Estrogen receptor breaks down protacs
GB201910305D0 (en) Compounds
IL289869A (en) Estrogen receptor modulating compounds
GB201908536D0 (en) Compounds
GB201912404D0 (en) New compounds
GB201910304D0 (en) Compounds
GB201908171D0 (en) Compounds
GB201908095D0 (en) Carboxy-MIDA-boronate compounds
GB201916595D0 (en) Compounds
GB201916572D0 (en) Compounds
GB201916597D0 (en) Compounds
GB201915318D0 (en) New compounds
GB201916142D0 (en) Compounds
GB201914208D0 (en) Compounds
GB201913633D0 (en) Compounds
GB201913541D0 (en) Compounds
GB201911942D0 (en) New compounds
GB201912850D0 (en) Compounds
GB201911848D0 (en) Compounds
GB201910885D0 (en) Compounds
GB201910607D0 (en) Compounds
GB201910608D0 (en) Compounds